Our top brands

Crosstex news

Cantel to Acquire Hu-Friedy
LITTLE FALLS, N.J., and CHICAGO, IL, July 30, 2019 – Cantel Medical Corp. (NYSE: CMD) (“Cantel”) today announced that it has reached an agreement to acquire Hu-Friedy Mfg. Co., LLC (“Hu-Friedy”), a 111-year-old global leading manufacturer of instruments and instrument reprocessing workflow systems serving the dental industry. After closing, Cantel will combine Hu-Friedy with its dental division, Crosstex, a global leader in infection prevention, sterility assurance, dental water management and conscious sedation systems. Read more here.
Cantel's Dental Division Expands Leadership Position in European Infection Prevention Market Following Acquisition of Omnia S.p.A.
Hauppauge, NY – (February 1, 2019) – Cantel Medical Corp. (NYSE:CMD), announced today that it has completed its previously announced acquisition to acquire Omnia S.p.A. (“Omnia”), an Italian-based market leader in dental surgical consumable solutions. The portfolio infection prevention solutions of Cantel’s Dental division, Crosstex International Inc. (“Crosstex”) will be further expanded to include Omnia’s wide-ranging portfolio of sutures, irrigation tubing and customized dental surgical procedure kits, with a focus on procedure room set-up and cross-contamination prevention. “Omnia’s comprehensive product lines of high-quality, innovative infection prevention and surgical solutions will be a strong addition to our growing dental portfolio,” said Gary Steinberg, President of Crosstex, Cantel’s Dental division. “We believe Omnia’s existing sales channels and focus on specialty dentistry will better equip us to service an additional segment of the dental market where maintaining aseptic procedures is critical.” “We are very excited to join Cantel’s Dental division,” stated Robert Cerioli, new Managing Director for Cantel’s European Dental business (formerly President of Omnia) “As a part of the Cantel organization, we are better equipped to service the dental practices and expand the adoption of both the Omnia and Crosstex portfolios within the European markets.” About Cantel Medical Corp. Cantel Medical Corp. is a leading global company dedicated to delivering innovative infection prevention products and services for patients, caregivers, and other healthcare providers, which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products. For further information, visit the Cantel website at www.cantelmedical.com. About Crosstex International, Inc. Crosstex International, Inc., the Dental division of Cantel Medical Corp., manufactures a wide array of unique and innovative infection prevention and compliance products for the global healthcare industry. Founded in 1953 and headquartered in Hauppauge, New York, Crosstex is a recognized leader for its portfolio of waterline treatment and compliance solutions, biological monitoring, sterility assurance, and preventive products, nitrous oxide sedation, and personal protection equipment (PPE). For further information, visit www.crosstex.com. About Omnia S.p.A. Omnia is a leading manufacturer and distributor of custom procedure kits, sutures and irrigation line systems, with a special focus on the set-up of the operating room and the prevention of cross-contamination. Omnia has a solid history of developing, manufacturing and selling innovative sterile and disposable surgical products. These products are specifically designed to meet the demanding requirements of dental surgery. For further information, visit the Omnia website at www.omniaspa.eu. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated. Contact: Janie Shen VP, Marketing Communications Crosstex International, Inc., Dental division of Cantel Medical Corp. 631-257-1306 janies@crosstex.com
Cantel Acquires Vista Research Group, LLC
Hauppauge, NY – (January 11, 2019) – Crosstex International, Inc. (“Crosstex”), the Dental division of Cantel Medical Corp. (NYSE:CMD) announced today that it has acquired Vista Research Group, LLC (“Vista Research Group”), a company that provides a complete line of innovative water treatment, purification and management solutions for the dental industry. Read More...